In fulminant hepatic failure, which marker is disproportionately elevated relative to others?

Prepare for the Clinical Chemistry Numericals Test. Study with comprehensive questions, each with detailed explanations. Boost your confidence and excel on your exam!

Multiple Choice

In fulminant hepatic failure, which marker is disproportionately elevated relative to others?

Explanation:
In fulminant hepatic failure, massive hepatocyte death releases enzymes into the blood, and the pattern of these elevations points to which enzyme dominates. The marker that rises disproportionately is AST. This is because AST exists in both cytosolic and mitochondrial parts of hepatocytes, and when severe necrosis occurs, mitochondrial membranes break down and release a large amount of AST. ALT, while elevated, is mainly cytosolic and does not rise as dramatically in this extreme injury. ALP and bilirubin reflect cholestasis and excretory problems, but they don’t surge to the same extent as the hepatocellular enzyme release in acute, massive liver cell death.

In fulminant hepatic failure, massive hepatocyte death releases enzymes into the blood, and the pattern of these elevations points to which enzyme dominates. The marker that rises disproportionately is AST. This is because AST exists in both cytosolic and mitochondrial parts of hepatocytes, and when severe necrosis occurs, mitochondrial membranes break down and release a large amount of AST. ALT, while elevated, is mainly cytosolic and does not rise as dramatically in this extreme injury. ALP and bilirubin reflect cholestasis and excretory problems, but they don’t surge to the same extent as the hepatocellular enzyme release in acute, massive liver cell death.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy